Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00503_DB08919_nanopub.RABaQgfhp3r97_u1BWUxo5wIUU9SSaAoGYQ3WRW0vcYLE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00503_DB08919 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00503_DB08919 label "DDI between Ritonavir and Zuclopenthixol acetate - Ritonavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if ritonavir is initiated, discontinued or dose changed. [drugbank_resource:DB00503_DB08919]" assertion.
- drugbank_resource:DB00503_DB08919 identifier "drugbank_resource:DB00503_DB08919" assertion.
- drugbank_resource:DB00503_DB08919 title "DDI between Ritonavir and Zuclopenthixol acetate - Ritonavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if ritonavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00503 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00503_DB08919 assertion.
- drugbank:DB08919 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00503_DB08919 assertion.